Drugs.com: Pandemic disrupting lung cancer screening
UC research shows how the COVID-19 pandemic impacted lung cancer screening, patient outcomes
COVID-19 caused significant disruption in lung cancer screening, according to a University of Cincinnati study published online in December in the Journal of the American College of Surgeons.
Robert Van Haren, lead author, assistant professor of surgery at UC, UC Health thoracic surgeon and member of the UC Cancer Center, and colleagues examined the impact of COVID-19 on lung cancer screening and subsequent cancer diagnosis among 2,153 patients from a screening database between January 2017 and July 2020.
"[Our] early analysis shows the unrecognized consequences related to the pandemic for screening programs and cancer care," Van Haren says.
Read the full Drugs.com article.
Featured photo of Robert Van Haren examining a lung image by Colleen Kelley.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.